- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00895986
Using Conversation Maps to Reinforce Self-Care
October 17, 2012 updated by: Joslin Diabetes Center
Achieving and Maintaining Glycemic Control: Using Conversation Maps to Reinforce Self-Care
Many people with type 2 diabetes are not able to keep their blood glucose in good control.
Improving blood glucose control and maintaining that improvement is important for diabetes patients because doing so delays the onset and progression of severe complications of diabetes.
Although educational programs may be helpful, their effect is not always long-lasting.
This project is studying whether the Conversation Maps program (an interactive diabetes education program) reinforces diabetes education and information and thus helps type 2 diabetes patients take better care of their diabetes and blood glucose levels.
Half of the patients will attend the Conversation Maps program and half of the patients will attend an educational program about blood pressure and cholesterol.
Also, all patients will come in for 4 or 5 appointments to complete surveys and other tests and have their blood drawn.
The group of patients who attend the Conversation Maps program will be compared to the group of patients who attend the blood pressure and cholesterol program to see if the educational programs helped diabetes patients to improve their diabetes control and quality of life and to maintain that improvement over time.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
134
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Joslin Diabetes Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ages 25-75 years
- Diagnosis of type 2 diabetes mellitus
- Two A1c levels ≥7.0 % (above ADA target)
- 2 years since initial diagnosis. This will provide a minimum of two-years experience with diabetes treatment. Also, excluding those who are newly diagnosed will prevent improvement due to newly prescribed medications from confounding study results.
- Attended one of Joslin's group education programs or comparable 3-hour (or more) educational programs and/or appointments
Exclusion Criteria:
- Severe complications of diabetes including renal disease (microalbumin >300 ug/mg), severe peripheral diabetic neuropathy and/or severe peripheral vascular disease, symptomatic severe autonomic neuropathy, that may place participants at risk when increasing activity levels.
- Proliferative diabetic retinopathy based on dilated eye examination within one year of study entry. Patients whose eye disease is successfully treated will be included.
- Current or planned pregnancy
- A1c levels less than 7.0% (normal range 4.0 - 6.0%) and A1c levels greater than 14%.
- A history of severe, unstable myocardial infarction, congestive heart failure or other severe cardiac disease, or severe hypertension (systolic ≥160 mmHg or diastolic ≥ 90 mmHg) (increased risk when mildly increasing physical activity).
- A diagnosis of bipolar disorder, schizophrenia, mental retardation, organic mental disorder, and alcohol or drug abuse will be excluded, as well as patients currently undergoing psychiatric treatment. These exclusions are being made to avoid confounds due to concurrent changes in mental status and the effects of ongoing psychiatric treatment.
- Used Conversation Maps as an educational tool
- Started a new diabetes medication (pills or insulin) in past three months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
Conversation Maps Diabetes Education
|
The Conversation Maps program is a set of innovative, interactive diabetes education tools developed by the Healthy Interactions, Inc (Healthy I) and endorsed by the American Diabetes Association.
It consists of four conversation maps covering: 1) Diabetes Overview, 2) Diabetes and Healthy Eating, 3) Blood Glucose and Monitoring, and 4) The Natural Course of Diabetes (a fifth map covering gestational diabetes will not be used in this study), and a program manual to help educators successfully implement the program.
|
Experimental: 2
Heart Healthy Living Diabetes Education
|
The Joslin Clinic offers a series of two 120-minute classes specifically for people with diabetes that address dyslipidemia and blood pressure problems.
A registered nurse and/or a registered dietitian teach the classes, which have a formal written curriculum, including PowerPoint slides.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Improved frequency of recommended self-care behaviors (Self-Care Inventory-R)
Time Frame: 3, 6, and 12 months post intervention
|
3, 6, and 12 months post intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
HbA1c
Time Frame: 3, 6, and 12 months post intervention
|
3, 6, and 12 months post intervention
|
Diabetes Quality of Life (scale)
Time Frame: 3, 6, and 12 months post intervention
|
3, 6, and 12 months post intervention
|
Major mediating/moderating variables include Problem Areas in Diabetes, Brief Symptom Inventory, Coping Styles, and Confidence in Diabetes
Time Frame: 3, 6, and 12 months post intervention
|
3, 6, and 12 months post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Katie Weinger, EdD, RN, Joslin Diabetes Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2008
Primary Completion (Actual)
March 1, 2012
Study Completion (Actual)
March 1, 2012
Study Registration Dates
First Submitted
May 7, 2009
First Submitted That Met QC Criteria
May 7, 2009
First Posted (Estimate)
May 11, 2009
Study Record Updates
Last Update Posted (Estimate)
October 18, 2012
Last Update Submitted That Met QC Criteria
October 17, 2012
Last Verified
October 1, 2012
More Information
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
-
University of Alabama at BirminghamUnited States Department of Defense; Loma Linda University; Brenda Davis Nutrition... and other collaboratorsCompletedType 2 Diabetes Mellitus
Clinical Trials on Conversation Maps Diabetes Education
-
University of Sao PauloUnknown
-
University of Sao PauloUnknown
-
M.D. Anderson Cancer CenterUnknown
-
Harvard School of Public Health (HSPH)RecruitingHealth Knowledge, Attitudes, PracticeUnited States
-
Dalin Tzu Chi General HospitalCompleted
-
Vanderbilt UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType 2 DiabetesUnited States
-
University of UtahCenters for Disease Control and PreventionCompletedDiabetes Mellitus, Type 2 | PreDiabetesUnited States
-
Medstar Health Research InstituteNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
State University of New York - Upstate Medical...TerminatedDiabetes MellitusUnited States
-
Centro de Endocrinologia Experimental y AplicadaNational Council of Scientific and Technical Research, ArgentinaCompletedType 2 DiabetesArgentina